In 8 of the 23 probands, targeted NGS identified a pathogenic mutation in a gene associated with dominant HL (ACTG1, CCDC50, EYA4, MYH14, MYO6, TCF21, and twice in MYO1A). The gene discussed is TCF21; the disease is Hodgkins lymphoma.